Malin has said it will invest in companies for which an initial public offering (IPO) or sale is premature

Malin has raised €330 million in one of Europe’s biggest biotechnology IPOs, a source close to the life sciences company has said, surpassing its tar(...)

Malin has said it will invest in companies for which an initial public offering (IPO) or trade sale is premature

Leading British fund manager Neil Woodford and the Irish state’s new strategic investment fund are among the investors who have committed to purchasin(...)

Former Elan chief executive Kelly Martin (pictured) and chairman Bob Ingram, who sold the Irish stock market stalwart to Perrigo for $8.6 billion in 2013, will sit on the board of Malin

Malin, an Irish company set up by a number of former Elan executives to invest in privately held life science assets, said it plans to raise between €(...)

Biotech fever is spreading to Europe from the United States with a successful stock market debut for a cat allergy company in Britain seen as a(...)

The fastest start to a year for US biotech initial public offerings is stoking fears of a bubble amid fears investors are taking increasing risks on c(...)